Inato and RealTime eClinical Solutions Partner to Deliver Unparalleled Site Performance and Patient Access Data to Sponsors

Today, Inato and RealTime eClinical Solutions announced a partnership to enhance site selection and trial enrollment. The partnership will unite RealTime-Devana's robust TrialAlign site data and Inato's trusted patient access data, providing sponsors and contract research organizations (CROs) with unparalleled insight and enabling them to choose sites that are both high-performing and ready to enroll.

Top sponsors rely on Inato's AI-enabled platform for early planning, site selection, and enrollment. Through this partnership, the 50+ large networks encompassing over 2,000 sites using RealTime-Devana today can join the 5,500+ sites on Inato, giving sponsors insight into TrialAlign's comprehensive, current site metrics data displayed in the Inato platform. This will significantly expand the pool of motivated, qualified sites sponsors can choose from, and create a more robust, seamless site selection experience.

The leading global site networks leverage RealTime-Devana's holistic business intelligence platform to enhance and accelerate their trial operations across pipeline management, study start-up automation, and dashboarding and reporting. Through this partnership with Inato, these sites will also gain preferred access to Inato's AI patient pre-screening solution for networks. AI patient pre-screening helps sites quickly identify and assess the right patients for each trial–shortening chart review times by up to 90%–and enables sites to showcase this data during feasibility, on the Inato and RealTime TrialAlign platforms. This meaningfully reduces site burden while also better positioning sites to access and win more trials.

"We built Inato to bring trials to all sites and patients. This partnership brings us a big step closer," said Kourosh Davarpanah, Co-founder and CEO, Inato. "By joining forces with RealTime's TrialAlign, we'll enable site networks to showcase proven patient access, activation speed, and enrollment performance to top sponsors, helping them secure the right trials for their patients."

"Unbiased site performance data plus patient access data is the holy grail in terms of site selection and trial feasibility. Through this partnership with Inato, this holy grail can be delivered to sponsors and CROs," said Barry Lake, Founder and President, RealTime-Devana. "Together, we help sites put their best foot forward and enable sponsors to confidently partner with sites based on proven performance, engagement, and readiness."

To learn more about Inato, visit www.inato.com. To learn more about RealTime-Devana, visit https://realtime-eclinical.com/solutions/devana/.

About Inato
Inato is on a mission to bring clinical research to every patient, regardless of where they live. The global technology company combines trial planning, site selection, and patient pre-screening into a single AI-enabled platform to transform the way research sites and sponsors work together to advance medical research. Leading pharmaceutical companies trust Inato to enhance trial accessibility and representation, and thousands of research sites leverage the platform to find the right research opportunities for their communities and streamline trial operations. For more information, visit www.inato.com.

About RealTime eClinical Solutions
RealTime eClinical Solutions is a leading eClinical technology provider reshaping clinical trials with its comprehensive eClinical platform. Purpose-built for clinical research sites, site networks, AMCs, sponsors, and CROs, the platform empowers modern-day clinical trial workflows from trial award and study start-up, through to trial execution. The suite includes CTMS, eReg/eISF, eSource, participant payments (SitePay/GlobalPay), engagement solutions (Text, eConsent, and MyStudyManager^™ Participant Portal), and Devana for study start-up, pipeline management, and performance metrics capture and analysis. Most recently, RealTime introduced TrialAlign, an advanced site selection, feasibility, and trial performance analytics platform. Visit www.realtime-eclinical.com.

Media Contact: press@inato.com and media@realtime-eclinical.com